TELA Bio was founded in 2011 with the mission of delivering transformational surgical experience toward improved patient outcomes. The company initially developed a line of implantable medical devices for soft tissue reinforcement and repair. In 2014, TELA Bio expanded its product portfolio with the launch of OviFix™ Surgical Mesh, the first patch specifically designed for transabdominal wall reinforcement, followed by OviTex® Surgical Mesh in 2016. As part of its mission, TELA Bio actively engages in compassionate programs to improve patient care.
